Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.068 | 0.2 |
mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |